JUN 11, 2016 10:03 AM PDT

New Agent Absorbs Toxic Drugs to Reduce Chemo Harm

WRITTEN BY: Xuan Pham
Killing cancer is only half the battle. Sparing healthy cells and tissues while defeating cancer is the other half that’s more difficult than it sounds. Scientists have attempted to solve this problem by making drugs that specifically target only the cancer cells. But researchers at the Lawrence Berkeley National Laboratory are taking a different approach. They’ve developed the equivalent of a chemical “sponge” that’s designed to soak up excess toxic anti-cancer drugs before it can harm healthy cells.
 
Roy Kaltschmidt/Berkeley LabThe chemical sponge is known formally as the ChemoFilter. It works by containing molecules with a strong affinity to the chemotherapeutic agent. In the picture shown here, the polymer material turns from a yellowish hue to a red after it binds chemotherapy drugs.
 
The idea for the first generation of ChemoFilters came about when researchers were working on polymer membranes. "We used to use this material for transporting protons in a fuel cell," said Xi Chen, who is co-author of the study. "I was really excited when I found out this could be used for chemotherapy -- this was branching out in a totally different direction."
 
Chen and the team realized that certain components of the polymer membrane had a strong negative electric charge. Like a magnet, the material works nicely to attract chemotherapy drugs that have a strong positive charge.
 
Doxorubicin, a common chemotherapy agent that’s positively charged, was a fitting model drug to test their ChemoFilter system. "In our lab experiments, the current design can absorb 90 percent of the drug in 25-30 minutes," said Chen.
 
"Doxorubicin has been around for decades. It is very well understood, and it is also very toxic," said Steven Hetts, associate professor at the University of California San Francisco, and who was the mastermind behind the ChemoFilter system. "If you get exposed to too much, when it goes through the heart you can go into heart failure.” Having a sponge that can soak up excess toxin could transform how doctors use this drug.
 


But an obvious concern is whether the sponge could negate the anti-cancer effects of the drugs on the actual tumor. For example, if the ChemoFilter is administered too soon then the chemotherapy agent won’t have enough time to act on the tumor. Timing, then, will be a crucial component to this new technology.
 
After demonstrating its effectiveness in animal studies, the ChemoFilter system received a patent from the FDA in April. The team is hopeful clinical trials will begin soon to test the device in patients. And if the device works as it’s supposed to, the team thinks it could actually increase the effectiveness of current drugs. “If you can remove a lot of the drug, you could escalate the dose of the drug you can give, for better tumor control and potentially a cure -- and you could basically eliminate any side effects,” said Hetts. 

Additional source: Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 24, 2019
Genetics & Genomics
NOV 24, 2019
22 Genes Discovered that Predict Skin Cancer from Sun Exposure
Australia has the highest rate of skin cancer in the world, with around 49 cases per 100,000 people. Now, researchers at the QIMR Berghofer Medical Researc...
NOV 24, 2019
Drug Discovery & Development
NOV 24, 2019
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
DEC 04, 2019
Cancer
DEC 04, 2019
Photon up-conversion for new cancer treatments
Scientists from the University of California, Riverside and The University of Texas at Austin have made a breakthrough in materials science that has signif...
DEC 18, 2019
Genetics & Genomics
DEC 18, 2019
Learning More About The Genetic Adaptations Cancer Relies On
Cancer cells can adapt to mutations in the genome that might kill the cells by altering the activity of their genes....
JAN 03, 2020
Drug Discovery & Development
JAN 03, 2020
New Drug Combo Reverses Breast Cancer
Researchers from Georgetown University have found that combining a drug used for epilepsy, bipolar disorder, and migraines with a drug used to ease blood p...
FEB 10, 2020
Cancer
FEB 10, 2020
New hope for KRAS-mutant pancreatic cancers
A study published recently in the journal Cancer Research showcases the findings from new research on pancreatic cancer. The study was led by Frank Mc...
Loading Comments...